文献速递银屑病与炎症性皮肤病

低度全身性炎症与普通人群银屑病风险相关:一项超过10万人的研究

Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100 000 individuals.
PubMed 文献 · Br J Dermatol · 2025-01-01

基于丹麦哥本哈根普通人群研究的前瞻性队列,纳入105 418名20-100岁个体,中位年龄58岁,55%为女性。测量全身免疫炎症指数(SII)、中性粒细胞与淋巴细胞比值(NLR)和C反应蛋白(CRP),随访近10年,发现这些炎症标志物水平升高与银屑病诊断风险独立相关,尤其与中重度银屑病相关。

要点

  • SII、NLR和CRP高水平(>90百分位)与银屑病风险增加独立相关。
  • 多变量调整后风险比分别为SII 1.78、NLR 1.56、CRP 2.83。
  • 结果支持低度全身性炎症可能参与银屑病发病,而非仅为其后果。

核心结论

  • 低度全身性炎症(以SII、NLR、CRP衡量)是银屑病的独立危险因素,尤其与中重度疾病相关。
  • 研究结果支持低度全身性炎症可能促进银屑病发病,而非仅仅是疾病的结果。

研究设计与样本

  • 研究使用哥本哈根普通人群研究数据,为前瞻性队列研究,纳入2003至2015年入组的20-100岁丹麦普通人群个体。
  • 共纳入105 418名个体,中位年龄58岁,55%为女性;入组时进行体检、填写生活方式问卷并采集血样测量SII、NLR和CRP。
  • 通过国际疾病分类代码与丹麦国家患者登记处 linkage 识别银屑病,采用Cox比例风险回归模型估计风险比,并调整性别、年龄、吸烟、饮酒、体力活动、教育水平、高血压、血脂异常和肥胖等混杂因素。

主要发现

  • SII、NLR和CRP水平升高与银屑病诊断风险增加相关。
  • 与低水平个体相比,SII>90百分位者的多变量调整风险比为1.78(95%CI 1.41-2.24)。
  • NLR>90百分位者的多变量调整风险比为1.56(95%CI 1.22-1.99)。
  • CRP>90百分位者的多变量调整风险比为2.83(95%CI 2.27-3.51)。
  • 使用局部卡泊三醇(单用或联合糖皮质激素)定义轻度银屑病时,结果相似但略有减弱。

临床怎么用

  • 研究提示低度全身性炎症可能先于银屑病诊断出现,支持其潜在致病作用。
  • 这些发现对日常临床实践的意义尚需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biomarkers of low-grade systemic inflammation have been reported to be higher in patients with psoriasis than in healthy controls. However, it is unknown whether this low-grade systemic inflammation contributes to the development of psoriasis or is merely a consequence. OBJECTIVES: To investigate whether low-grade systemic inflammation, measured as systemic immune-inflammation index (SII), neutrophil-to-lymphocyte ratio (NLR) or C-reactive protein (CRP), is an independent risk factor for psoriasis. METHODS: We used data from the Copenhagen General Population Study, a prospective cohort study of the Danish general population where individuals aged 20-100 years were enrolled between 2003 and 2015. Upon enrolment in the study, all individuals underwent a physical examination, completed an extensive self-reported questionnaire regarding lifestyle, and provided blood samples, from which SII, NLR and CRP were measured. Psoriasis was identified using International Classification of Diseases codes with individual linkage to the Danish National Patient Registry. Associations between SII, NLR and CRP and psoriasis were estimated using hazard ratios from Cox proportional hazard regression models. Analyses were adjusted for potential confounders including sex, age, smoking, alcohol consumption, physical activity, educational level, hypertension, dyslipidaemia and obesity. RESULTS: We included 105 418 individuals with a median age of 58 years, 55% of whom were women. The risk of receiving a diagnosis of psoriasis increased with increasing levels of SII, NLR and CRP. In individuals with high levels (> 90th percentile) of SII, NLR and CRP, the multivariable adjusted hazard ratios were 1.78 [95% confidence interval (CI) 1.41-2.24], 1.56 (95% CI 1.22-1.99) and 2.83 (95% CI 2.27-3.51), respectively, compared with individuals with low levels. Results were similar but slightly attenuated when we used topical calcipotriol (alone or in combination with corticosteroids) for mild psoriasis. CONCLUSIONS: We found that low-grade systemic inflammation, as measured by SII, NLR and CRP, was an independent risk factor for psoriasis, especially moderate-to-severe disease. These findings support the hypothesis that low-grade systemic inflammation may contribute to the pathogenesis of psoriasis rather than simply being a consequence of the disease. Psoriasis is a chronic inflammatory skin condition that affects around 3% of the adult population in Western Europe. Psoriasis is characterized by raised patches of skin with redness and scaling. The most commonly affected areas of the body include the scalp, elbows and knees. The symptoms of psoriasis can be painful and can have a negative impact on a person’s quality of life. The exact mechanisms underlying psoriasis are complex and not yet fully understood. Both genetic and environmental factors play a role. For example, inflammation in psoriasis can be detected using biomarkers (molecules in the blood associated with disease) in the skin and blood. However, we do not know whether the inflammation in the blood is a consequence of the inflammation in the skin or vice versa. In this study, we hypothesized that inflammation in the blood is an independent risk factor for psoriasis, rather than a consequence of the disease. We studied over 100,000 Danish people who were enrolled in the Copenhagen General Population Study. Each participant volunteered a blood sample when they entered the study. The participants were followed for nearly 10 years. Psoriasis was identified using the Danish health registries. We found that increased inflammation in the blood was associated with a higher risk of being diagnosed with psoriasis. Our findings support the idea that pre-existing systemic inflammation may trigger later psoriasis. This would mean that such inflammation is not merely the consequence of the disease. The usefulness of these findings and the implications for daily clinical practice need further study.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Näslund-Koch C, Kvist-Hansen A, Bojesen SE, et al. Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100 000 individuals. Br J Dermatol. 2025. PMID: 40249082. doi:10.1093/bjd/ljaf147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。